偏头痛指南巡讲__培训课件.ppt

* * * 用眼卫生，注意用眼疲劳，纠正屈光不正 * * * * * * * * * * * * * * * * * * * * * * * 意大利常用药 * * *  * * * References: 1. Storer RJ, Akerman S, Goadsby PJ. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol. 2004;142(7):1171–1181. 2. Jenkins DW, Langmead CJ, Parsons AA, Strijbos PJ. Regulation of calcitonin gene-related peptide release from rat trigeminal nucleus caudalis slices in vitro. Neurosci Lett. 2004;366(3):241–244. 3. Moskowitz MA. Basic mechanisms in vascular headache. Neurol Clin. 1990;8(4):801–815. 4. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28(2):183-187. 5. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J. CGRP may play a causative role in migraine. Cephalalgia. 2002;22(1):54–61. 6. Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol. 1988;23(2):193–196. 7. Lennerz JK, Rühle V, Ceppa EP, et al. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol. 2008;507(3):1277–1299. 8. Thalakoti S, Patil VV, Damodaram S, et al. Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache. 2007;47(7):1008–1023. 9. Dodick D, Silberstein S. Central sensitization theory of migraine: clinical implications. Headache. 2006;46(suppl 4):S182–S191. 10. Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med. 2007;13(1):39–44. 11. Sexton PM, McKenzie JS, Mason RT, Moseley JM, Martin TJ, Mendelsohn FAO. Localization of binding sites for calcitonin